• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Zogenix, Inc. (ZGNX)

    -NasdaqGM
    1.33 0.05(3.91%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:1.28
    Open:1.29
    Bid:1.18 x 2000
    Ask:N/A
    1y Target Est:2.75
    Beta:1.12
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:1.28 - 1.34
    52wk Range:1.07 - 5.19
    Volume:1,664,223
    Avg Vol (3m):2,112,210
    Market Cap:203.54M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ZGNXUp 3.91%203.54M
    AZN89.13B
    GSK108.64B
    PFE206.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.66
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback